Sumitomo Pharma America Doses First Patient With DSP-3077
MARLBOROUGH, Mass., August 12, 2026 Sumitomo Pharma America, Inc. announced that the first patient has received treatment with DSP-3077...
Manufacturing
Advertisement
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months
BURLINGTON, Mass., August 12, 2026 Bone Biologics Corporation announced that its rhNELL-1 protein has achieved a validated shelf life...
Asimov Completes Biosimilar Antibody Cell Line Campaign with Kyungdong
Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...
Scholar Rock Advances Apitegromab FDA Review with Second Fill-Finish Facility
CAMBRIDGE, Mass., August 7, 2026 Scholar Rock announced that the U.S. Food and Drug Administration (FDA) review of its...
Moderna Begins Phase 1 Trial for Ebola mRNA Vaccine
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
Advertisements
Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar
HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
Regentis Wins European Approval for New GelrinC Process
HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...
Telix Opens Australia’s First Integrated Radiopharmaceutical Facility for Cancer Care
MELBOURNE, Australia & INDIANAPOLIS, Ind., July 16, 2026 Telix has officially opened Telix Manufacturing Solutions North Melbourne (TMSNM), Australia’s...
IntelliGenome Wins INVIMA Approval for CRISPR-TB Test
HOUSTON, Texas & BOGOTÁ, Colombia, June 29, 2026 IntelliGenome, Inc. has received sanitary registration approval from Colombia’s National Institute...
Advertisement
